DETERMINATION OF ZOLPIDEM, A NEW SLEEP-INDUCING AGENT, AND ITS METABOLITES IN BIOLOGICAL-FLUIDS - PHARMACOKINETICS, DRUG-METABOLISM AND OVERDOSING INVESTIGATIONS IN HUMANS

被引:39
作者
ASCALONE, V [1 ]
FLAMINIO, L [1 ]
GUINEBAULT, P [1 ]
THENOT, JP [1 ]
MORSELLI, PL [1 ]
机构
[1] SYNTHELABO RECH,DEPT CLIN RES,F-75013 PARIS,FRANCE
来源
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 1992年 / 581卷 / 02期
关键词
D O I
10.1016/0378-4347(92)80277-W
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
For the determination of zolpidem, a new sleep inducer, and its metabolites in human plasma and urine, three methods were developed that are suitable for pharmacokinetics, drug metabolism and overdosing investigations. The methods used for pharmacokinetic and drug metabolism studies are based on column-switching high-performance liquid chromatography; they do not require any sample manipulation because the plasma or diluted urine is injected into a pre-column where clean-up and preconcentration take place. The analytes are transferred by valve-switching to the C18 analytical column for chromatography. To investigate overdose cases, urine samples only are used: the method is simple, because the diluted urine can be injected directly into the analytical column (phenyl type). This allows the identification and quantification of the principal urinary metabolite of zolpidem, the unchanged drug being practically undetectable. All the methods use fluorescence detection, which affords high sensitivity and selectivity. It is necessary to use a method capable of the determination of metabolites even if these are apparently pharmacologically inactive, because in different physiopathological populations the qualitative and quantitative metabolic profiles of zolpidem could be different. The method designed for the investigation of (accidental or deliberate) overdose cases is, as required on such occasions, simple and rapid, with good selectivity with respect to commonly prescribed psychotropic drugs.
引用
收藏
页码:237 / 250
页数:14
相关论文
共 14 条
[11]  
LILIE JK, 1989, SLEEP RES, V18, P122
[12]  
MORSELLI PL, 1988, IMIDAZOPYRIDINES SLE, P183
[13]  
THENOT JP, 1988, IMIDAZOPYRIDINES SLE, P139
[14]  
ZIVKOVIC B, 1991, BIOL PSYCHIAT, V1, P856